University Of Notre Dame Du Lac Heron Therapeutics, Inc. Transaction History

University Of Notre Dame Du Lac

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $569,416 - $1.12 Million	-52,288 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $65,758 - $157,871	6,428 Added 14.02%	52,288 $614,000
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $118,752 - $181,400	-6,817 Reduced 12.94%	45,860 $1.08 Million
Q3 2019 Nov 13, 2019	SELL	$16.36 - $21.39 $2.45 Million - $3.21 Million	-150,016 Reduced 74.01%	52,677 $975,000
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $3.56 Million - $5.51 Million	-210,012 Reduced 50.89%	202,693 $3.77 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $7.34 Million - $8.98 Million	316,969 Added 331.09%	412,705 $10.1 Million
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $983,198 - $1.43 Million	-44,630 Reduced 31.8%	95,736 $2.48 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $1.61 Million - $2.19 Million	53,650 Added 61.87%	140,366 $4.44 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $2.29 Million - $3.64 Million	86,716 New	86,716 $3.37 Million

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $210M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.